{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:26:01Z","timestamp":1793532361609,"version":"4.5.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1093\/ije\/30.6.1415","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:28:32Z","timestamp":1027722512000},"page":"1415-1425","source":"Crossref","is-referenced-by-count":168,"title":["Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database"],"prefix":"10.1093","volume":"30","author":[{"given":"Douglas A","family":"Corley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A","family":"Buffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12]]},"reference":[{"key":"key\n\t\t\t\t20170712064107_R1","unstructured":"Munoz N, Day NE. Esophageal Cancer. In: Schottenfeld D, Fraumeni JF (eds). Cancer Epidemiology and Prevention. New York: Oxford University Press, 1996, pp.681\u2013706."},{"key":"key\n\t\t\t\t20170712064107_R2","doi-asserted-by":"crossref","unstructured":"Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer1996;78:1820\u201328.","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z"},{"key":"key\n\t\t\t\t20170712064107_R3","doi-asserted-by":"crossref","unstructured":"McKinney A, Sharp L, Macfarlane GJ, Muir CS. Oesophageal and gastric cancer in Scotland 1960\u201390. Br J Cancer1995;71:411\u201315.","DOI":"10.1038\/bjc.1995.84"},{"key":"key\n\t\t\t\t20170712064107_R4","doi-asserted-by":"crossref","unstructured":"Hansson LE, Sparaen P, Nyraen O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer1993;54:402\u201307.","DOI":"10.1002\/ijc.2910540309"},{"key":"key\n\t\t\t\t20170712064107_R5","doi-asserted-by":"crossref","unstructured":"Hansson LE, Sparaen P, Nyraen O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg1993;80:374\u201377.","DOI":"10.1002\/bjs.1800800338"},{"key":"key\n\t\t\t\t20170712064107_R6","doi-asserted-by":"crossref","unstructured":"Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer1998;83:2049\u201353.","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2"},{"key":"key\n\t\t\t\t20170712064107_R7","doi-asserted-by":"crossref","unstructured":"Hansen S, Wiig JN, Giercksky KE, Tretli S. Esophageal and gastric carcinoma in Norway 1958\u20131992: incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer1997;71:340\u201344.","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<340::AID-IJC5>3.0.CO;2-Y"},{"key":"key\n\t\t\t\t20170712064107_R8","doi-asserted-by":"crossref","unstructured":"Lord RV, Law MG, Ward RL, Giles GG, Thomas RJ, Thursfield V. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol1998;13:356\u201362.","DOI":"10.1111\/j.1440-1746.1998.tb00646.x"},{"key":"key\n\t\t\t\t20170712064107_R9","doi-asserted-by":"crossref","unstructured":"Thomas RJ, Lade S, Giles GG, Thursfield V. Incidence trends in oesophageal and proximal gastric carcinoma in Victoria. Aust NZ J Surg1996;66:271\u201375.","DOI":"10.1111\/j.1445-2197.1996.tb01183.x"},{"key":"key\n\t\t\t\t20170712064107_R10","doi-asserted-by":"crossref","unstructured":"Levi F, La Vecchia C. Adenocarcinoma of the esophagus in Switzerland [letter; comment]. JAMA1991;265:2960.","DOI":"10.1001\/jama.1991.03460220048021"},{"key":"key\n\t\t\t\t20170712064107_R11","doi-asserted-by":"crossref","unstructured":"Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histologic type. Cancer1988;61:612\u201317.","DOI":"10.1002\/1097-0142(19880201)61:3<612::AID-CNCR2820610332>3.0.CO;2-Q"},{"key":"key\n\t\t\t\t20170712064107_R12","doi-asserted-by":"crossref","unstructured":"Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology1993;104:510\u201313.","DOI":"10.1016\/0016-5085(93)90420-H"},{"key":"key\n\t\t\t\t20170712064107_R13","doi-asserted-by":"crossref","unstructured":"Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer1990;62:440\u201343.","DOI":"10.1038\/bjc.1990.314"},{"key":"key\n\t\t\t\t20170712064107_R14","doi-asserted-by":"crossref","unstructured":"Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia [see comments]. JAMA1991;265:1287\u201389.","DOI":"10.1001\/jama.265.10.1287"},{"key":"key\n\t\t\t\t20170712064107_R15","doi-asserted-by":"crossref","unstructured":"Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update [letter]. JAMA1993;270:1320.","DOI":"10.1001\/jama.1993.03510110056031"},{"key":"key\n\t\t\t\t20170712064107_R16","unstructured":"Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol1999;26:2\u20138."},{"key":"key\n\t\t\t\t20170712064107_R17","doi-asserted-by":"crossref","unstructured":"Escobedo LG, Peddicord JP. Smoking prevalence in US birth cohorts: the influence of gender and education. Am J Public Health1996;86: 231\u201336.","DOI":"10.2105\/AJPH.86.2.231"},{"key":"key\n\t\t\t\t20170712064107_R18","doi-asserted-by":"crossref","unstructured":"Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol2000;29: 645\u201354.","DOI":"10.1093\/ije\/29.4.645"},{"key":"key\n\t\t\t\t20170712064107_R19","unstructured":"Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. Lyon: International Agency for Research on Cancer, 1993."},{"key":"key\n\t\t\t\t20170712064107_R20","unstructured":"Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol. VII. Lyon: International Agency for Research on Cancer, 1997."},{"key":"key\n\t\t\t\t20170712064107_R21","unstructured":"Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research, Volume IV: Descriptive Epidemiology. Lyon: International Agency for Research on Cancer, 1994."},{"key":"key\n\t\t\t\t20170712064107_R22","unstructured":"Bishop Y, Finberg S, Holland P. Discrete Multivariate Analysis: Theory and Practice. Cambridge, MS: MIT Press, 1975."},{"key":"key\n\t\t\t\t20170712064107_R23","doi-asserted-by":"crossref","unstructured":"Brewster DH, Fraser LA, McKinney PA, Black RJ. Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland. Br J Cancer2000;83:387\u201390.","DOI":"10.1054\/bjoc.2000.1110"},{"key":"key\n\t\t\t\t20170712064107_R24","doi-asserted-by":"crossref","unstructured":"Dolan K, Sutton R, Walker SJ, Morris AI, Campbell F, Williams EM. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer1999;80:834\u201342.","DOI":"10.1038\/sj.bjc.6690429"},{"key":"key\n\t\t\t\t20170712064107_R25","doi-asserted-by":"crossref","unstructured":"Levi F, Te VC, Randimbison L, La Vecchia C. Re: Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence [letter]. J Natl Cancer Inst1999;91:1585\u201386.","DOI":"10.1093\/jnci\/91.18.1585A"},{"key":"key\n\t\t\t\t20170712064107_R26","unstructured":"Chow WH, Blaser MJ, Blot WJ et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res1998;58:588\u201390."},{"key":"key\n\t\t\t\t20170712064107_R27","doi-asserted-by":"crossref","unstructured":"Paerez-Paerez GI, Bhat N, Gaensbauer J et al. Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections. Int J Cancer1997;72:453\u201356.","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<453::AID-IJC13>3.0.CO;2-D"},{"key":"key\n\t\t\t\t20170712064107_R28","doi-asserted-by":"crossref","unstructured":"Webb PM, Crabtree JE, Forman D. Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology1999;116: 269\u201376.","DOI":"10.1016\/S0016-5085(99)70122-8"},{"key":"key\n\t\t\t\t20170712064107_R29","doi-asserted-by":"crossref","unstructured":"Lagergren J, Bergstrom R, Adami HO, Nyren O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma [see comments]. Ann Intern Med2000;133:165\u201375.","DOI":"10.7326\/0003-4819-133-3-200008010-00007"},{"key":"key\n\t\t\t\t20170712064107_R30","doi-asserted-by":"crossref","unstructured":"Vicari JJ, Peek RM, Falk GW et al. The seroprevalence of cagA-positive Helicobacter pylori trains in the spectrum of gastroesophageal reflux disease. Gastroenterology1998;115:50\u201357.","DOI":"10.1016\/S0016-5085(98)70364-6"},{"key":"key\n\t\t\t\t20170712064107_R31","doi-asserted-by":"crossref","unstructured":"Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma [see comments]. N Engl J Med1999;340:825\u201331.","DOI":"10.1056\/NEJM199903183401101"},{"key":"key\n\t\t\t\t20170712064107_R32","doi-asserted-by":"crossref","unstructured":"Tzonou A, Lipworth L, Garidou A et al. Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer1996;68:300\u201304.","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<300::AID-IJC6>3.0.CO;2-5"},{"key":"key\n\t\t\t\t20170712064107_R33","doi-asserted-by":"crossref","unstructured":"Brown LM, Swanson CA, Gridley G et al. Adenocarcinoma of the esophagus: role of obesity and diet [see comments]. J Natl Cancer Inst1995;87.","DOI":"10.1093\/jnci\/87.2.104"},{"key":"key\n\t\t\t\t20170712064107_R34","doi-asserted-by":"crossref","unstructured":"Heini AF, Weinsier RL. Divergent trends in obesity and fat intake patterns: the American paradox. Am J Med1997;102:259\u201364.","DOI":"10.1016\/S0002-9343(96)00456-1"},{"key":"key\n\t\t\t\t20170712064107_R35","doi-asserted-by":"crossref","unstructured":"Brown LM, Silverman DT, Pottern LM et al. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control1994;5:333\u201340.","DOI":"10.1007\/BF01804984"},{"key":"key\n\t\t\t\t20170712064107_R36","doi-asserted-by":"crossref","unstructured":"Gammon MD, Schoenberg JB, Ahsan H et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia [see comments]. J Natl Cancer Inst1997;89:1277\u201384.","DOI":"10.1093\/jnci\/89.17.1277"},{"key":"key\n\t\t\t\t20170712064107_R37","unstructured":"Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev1995;4:85\u201392."},{"key":"key\n\t\t\t\t20170712064107_R38","doi-asserted-by":"crossref","unstructured":"Lagergren J, Bergstrom R, Lindgren A, Nyren O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer2000;85:340\u201346.","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<340::AID-IJC8>3.0.CO;2-N"},{"key":"key\n\t\t\t\t20170712064107_R39","doi-asserted-by":"crossref","unstructured":"Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg1999;86:529\u201335.","DOI":"10.1046\/j.1365-2168.1999.01082.x"},{"key":"key\n\t\t\t\t20170712064107_R40","doi-asserted-by":"crossref","unstructured":"Farrow DC, Vaughan TL, Sweeney C et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control2000;11:231\u201338.","DOI":"10.1023\/A:1008913828105"},{"key":"key\n\t\t\t\t20170712064107_R41","doi-asserted-by":"crossref","unstructured":"Terry P, Lagergren J, Ye W, Nyren O, Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer2000;87:750\u201354.","DOI":"10.1002\/1097-0215(20000901)87:5<750::AID-IJC19>3.0.CO;2-6"},{"key":"key\n\t\t\t\t20170712064107_R42","doi-asserted-by":"crossref","unstructured":"Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med1999;130:883\u201390.","DOI":"10.7326\/0003-4819-130-11-199906010-00003"},{"key":"key\n\t\t\t\t20170712064107_R43","doi-asserted-by":"crossref","unstructured":"Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology1999;117:218\u201328.","DOI":"10.1016\/S0016-5085(99)70571-8"},{"key":"key\n\t\t\t\t20170712064107_R44","doi-asserted-by":"crossref","unstructured":"Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res2000;155:1\u201314.","DOI":"10.1007\/978-3-642-59600-1_1"},{"key":"key\n\t\t\t\t20170712064107_R45","doi-asserted-by":"crossref","unstructured":"Peek RM Jr, Vaezi MF, Falk GW et al. Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer1999;82:520\u201324.","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<520::AID-IJC9>3.0.CO;2-7"},{"key":"key\n\t\t\t\t20170712064107_R46","doi-asserted-by":"crossref","unstructured":"Polkowski W, van Lanschot JJ, ten Kate FJ et al. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett' esophagus. Am J Gastroenterol2000;95:617\u201325.","DOI":"10.1111\/j.1572-0241.2000.01833.x"},{"key":"key\n\t\t\t\t20170712064107_R47","doi-asserted-by":"crossref","unstructured":"Ruol A, Parenti A, Zaninotto G et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett' esophagus and adenocarcinoma of the gastric cardia. Cancer2000;88:2520\u201328.","DOI":"10.1002\/1097-0142(20000601)88:11<2520::AID-CNCR13>3.0.CO;2-L"},{"key":"key\n\t\t\t\t20170712064107_R48","doi-asserted-by":"crossref","unstructured":"Griffel LH, Amenta PS, Das KM. Use of a novel monoclonal antibody in diagnosis of Barrett' esophagus. Dig Dis Sci2000;45:40\u201348.","DOI":"10.1023\/A:1005449024524"},{"key":"key\n\t\t\t\t20170712064107_R49","doi-asserted-by":"crossref","unstructured":"Das KM, Prasad I, Garla S, Amenta PS. Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann Intern Med1994;120:753\u201356.","DOI":"10.7326\/0003-4819-120-9-199405010-00006"},{"key":"key\n\t\t\t\t20170712064107_R50","doi-asserted-by":"crossref","unstructured":"Boch JA, Shields HM, Antonioli DA, Zwas F, Sawhney RA, Trier JS. Distribution of cytokeratin markers in Barrett' specialized columnar epithelium. Gastroenterology1997;112:760\u201365.","DOI":"10.1053\/gast.1997.v112.pm9041237"},{"key":"key\n\t\t\t\t20170712064107_R51","doi-asserted-by":"crossref","unstructured":"Salo JA, Kivilaakso EO, Kiviluoto TA, Virtanen IO. Cytokeratin profile suggests metaplastic epithelial transformation in Barrett' oesophagus. Ann Med1996;28:305\u201309.","DOI":"10.3109\/07853899608999085"},{"key":"key\n\t\t\t\t20170712064107_R52","unstructured":"van Dekken H, Geelen E, Dinjens WN et al. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett') and gastric cardia adenocarcinomas. Cancer Res1999;59:748\u201352."},{"key":"key\n\t\t\t\t20170712064107_R53","doi-asserted-by":"crossref","unstructured":"Ireland AP, Shibata DK, Chandrasoma P, Lord RV, Peters JH, DeMeester TR. Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg2000;231:179\u201387.","DOI":"10.1097\/00000658-200002000-00005"},{"key":"key\n\t\t\t\t20170712064107_R54","doi-asserted-by":"crossref","unstructured":"Beuzen F, Dubois S, Flejou JF. Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in-situ hybridization. Histopathology2000;37:241\u201349.","DOI":"10.1046\/j.1365-2559.2000.00887.x"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/30\/6\/1415\/18524942\/301415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:28:53Z","timestamp":1583310533000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/30.6.1415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2001,12]]},"published-print":{"date-parts":[[2001,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/30.6.1415","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}